The DNA methylation drift of the atherosclerotic aorta increases with lesion progression

BMC Medical Genomics

Volumn 8, Issue 1, 2015, Pages

  Del Pilar Valencia Morales, María ^f   Zaina, Silvio ^a,b   Heyn, Holger ^b   Carmona, F Javier ^b   Varol, Nuray ^b   Sayols, Sergi ^b   Condom, Enric ^c,d   Ramírez Ruz, José ^e   Gomez, Antonio ^b   Moran, Sebastian ^b   Lund, Gertrud ^f   Rodríguez Ríos, Dalia ^f   López González, Gladys ^a   Ramírez Nava, Magda ^a   De La Rocha, Carmen ^f   Sanchez Flores, Alejandro ^g   Esteller, Manel ^b,d,h  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f DEPARTAMENTO DE FÍSICA   (Mexico)

^g INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

^h INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Aorta; Atherosclerosis; DNA methylation; Genome wide analysis

Indexed keywords

GENOMIC DNA; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

AORTA ATHEROSCLEROSIS; AORTA INJURY; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DNA METHYLATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SYNDROME DELINEATION; ANIMAL; AORTA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; C57BL MOUSE; CLUSTER ANALYSIS; DNA MICROARRAY; GENETIC DATABASE; GENETIC EPIGENESIS; GENETICS; IMMUNE SYSTEM; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; MOUSE; PATHOLOGY;

MURINAE;

ANIMALS; AORTA; ATHEROSCLEROSIS; CLUSTER ANALYSIS; CPG ISLANDS; DATABASES, GENETIC; DISEASE PROGRESSION; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLAQUE, ATHEROSCLEROTIC; TRANSCRIPTION FACTORS;

EID: 84928028386     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/s12920-015-0085-1     Document Type: Article

References (40)

1. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature. 2007;447:425-32.
2. Szulwach KE, Jin P. Integrating DNA methylation dynamics into a framework for understanding epigenetic codes. Bioessays. 2014;36:107-17.
3. Apostolou E, Hochedlinger K. Chromatin dynamics during cellular reprogramming. Nature. 2013;502:462-71.
4. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol. 2003;23:5293-300.
5. Newman PE. Can reduced folic acid and vitamin B12 levels cause deficient DNA methylation producing mutations which initiate atherosclerosis? Med Hypotheses. 1999;53:421-4.
6. Ordovás JM, Smith CE. Epigenetics and cardiovascular disease. Nat Rev Cardiol. 2010;7:510-9.
7. Laukkanen MO, Mannermaa S, Hiltunen MO, Aittomäki S, Airenne K, Jänne J, et al. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler Thromb Vasc Biol. 1999;19:2171-8.
8. Zaina S. Unraveling the DNA methylome of atherosclerosis. Curr Opin Lipidol. 2014;25:148-53.
9. Zaina S, Heyn H, Carmona FJ, Varol N, Sayols S, Condom E, et al. A DNA methylation map of human atherosclerosis. Circ Cardiovasc Genet. 2014;7:692-700.
10. Dunn J, Qiu H, Kim S, Jjingo D, Hoffman R, Kim CW, et al. Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis. J Clin Invest. 2014;124:3187-99.
11. Cao Q, Wang X, Jia L, Mondal AK, Diallo A, Hawkins GA, et al. Inhibiting DNA Methylation by 5-aza-2′-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology. 2014. [Epub ahead of print].
12. Irvin MR, Zhi D, Joehanes R, Mendelson M, Aslibekyan S, Claas SA, et al. Epigenome-wide association study of fasting blood lipids in the genetics of lipid lowering drugs and diet network study. Circulation. 2014. [Epub ahead of print].
13. Hidalgo B, Irvin MR, Sha J, Zhi D, Aslibekyan S, Absher D, et al. Epigenomewide association study of fasting measures of glucose, insulin, and HOMA-IR in the genetics of lipid lowering drugs and diet network study. Diabetes. 2014;63:801-7.
14. Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, Aïssi D, Wahl S, et al. DNA methylation and body-mass index: a genome-wide analysis. Lancet. 2014;383:1990-8.
15. Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana MA, Bibikova M, et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics. 2011;6:692-702.
16. Heyn H, Li N, Ferreira HJ, Moran S, Pisano DG, Gomez A, et al. Distinct DNA methylomes of newborns and centenarians. Proc Natl Acad Sci U S A. 2012;109:10522-7.
17. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468-71.
18. Li H, Durbin R. Fast and accurate short read alignment with burrowswheeler transform. Bioinformatics. 2009;25:1754-60.
19. Tarazona S, Garcia-Alcalde F, Dopazo J, Ferrer A, Conesa A. Differential expression in RNA-seq: a matter of depth. Genome Res. 2011;21:4436.
20. Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, et al. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics. 2010;11:587.
21. George SJ, Williams A, Newby AC. An essential role for platelet-derived growth factor in neointima formation in human saphenous vein in vitro. Atherosclerosis. 1996;120:227-40.
22. Pinheiro I, Margueron R, Shukeir N, Eisold M, Fritzsch C, Richter FM, et al. Prdm3 and Prdm16 are H3K9me1 methyltransferases required for mammalian heterochromatin integrity. Cell. 2012;150:948-60.
23. Hondares E, Rosell M, Díaz-Delfín J, Olmos Y, Monsalve M, Iglesias R, et al. Peroxisome proliferator-activated receptor α (PPARα) induces PPARγ coactivator 1α (PGC-1α) gene expression and contributes to thermogenic activation of brown fat: involvement of PRDM16. J Biol Chem. 2011;286:43112-22.
24. Puig O, Yuan J, Stepaniants S, Zieba R, Zycband E, Morris M, et al. A gene expression signature that classifies human atherosclerotic plaque by relative inflammation status. Circ Cardiovasc Genet. 2011;4:595-604.
25. Karagiannis GS, Weile J, Bader GD, Minta J. Integrative pathway dissection of molecular mechanisms of moxLDL-induced vascular smooth muscle phenotype transformation. BMC Cardiovasc Disord. 2013;13:4.
26. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferatoractivated receptor-gamma is a negative regulator of macrophage activation. Nature. 1998;391:79-82.
27. Stylianou IM, Bauer RC, Reilly MP, Rader DJ. Genetic basis of atherosclerosis: insights from mice and humans. Circ Res. 2012;110:337-55.
28. Gibbs JR, van der Brug MP, Hernandez DG, Traynor BJ, Nalls MA, Lai SL, et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 2010;6:e1000952.
29. Sharma P, Kumar J, Garg G, Kumar A, Patowary A, Karthikeyan G, et al. Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol. 2008;27:357-65.
30. Huang YS, Zhi YF, Wang SR. Hypermethylation of estrogen receptor-alpha gene in atheromatosis patients and its correlation with homocysteine. Pathophysiology. 2009;16:259-65.
31. Zawada AM, Rogacev KS, Hummel B, Grün OS, Friedrich A, Rotter B, et al. SuperTAG methylation-specific digital karyotyping reveals uremia-induced epigenetic dysregulation of atherosclerosis-related genes. Circ Cardiovasc Genet. 2012;5:611-20.
32. Zhang D, Chen Y, Xie X, Liu J, Wang Q, Kong W, et al. Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells. J Mol Cell Cardiol. 2012;53:487-96.
33. Zhu S, Goldschmidt-Clermont PJ, Dong C. Inactivation of monocarboxylate transporter MCT3 by DNA methylation in atherosclerosis. Circulation. 2005;112:1353-61.
34. Lorincz MC, Dickerson DR, Schmitt M, Groudine M. Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells. Nat Struct Mol Biol. 2004;11:1068-75.
35. Flanagan JM, Wild L. An epigenetic role for noncoding RNAs and intragenic DNA methylation. Genome Biol. 2007;8:307.
36. Shimizu H, Mitomo K, Watanabe T, Okamoto S, Yamamoto K. Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol. 1990;10:561-8.
37. Covic M, Hassa PO, Saccani S, Buerki C, Meier NI, Lombardi C, et al. Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaBdependent gene expression. EMBO J. 2005;24:85-96.
38. Wang L, Fan C, Topol SE, Topol EJ, Wang Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science. 2003;302:1578-81.
39. Zhao W, Zhao SP, Peng DQ. The effects of myocyte enhancer factor 2A gene on the proliferation, migration and phenotype of vascular smooth muscle cells. Cell Biochem Funct. 2012;30:108-13.
40. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-26.